Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents : a randomized, multicenter controlled trial (ETICCO study)
PURPOSE: The use of oral cancer drugs (OAD) has increased over the last two decades. The objective of this study was to measure the impact of a nurse-led telephone follow-up in the therapeutic management of patients treated with an OAD regarding toxicity, medication adherence and quality of life.
METHODS: A randomized, multicenter, controlled trial was conducted. All consecutive over 18-year-old patients, treated in medical oncology, radiotherapy, or hematology departments, receiving OAD for any cancer were invited to participate to the study. A total of 183 patients treated for solid or hematological cancers with an OAD were randomly assigned to receive a nurse-led telephone follow-up or standard care for 24 weeks. Data were collected between 2015 and 2018.
RESULTS: Nurse telephone follow-up did not improve the global score toxicity in the intervention group. However, telephone calls directed by trained nurses induced a significant decrease in number of patients with grade 3 adverse events throughout the follow-up [OR 0.45 (IC à 95%) (0.23, 0.9)](P = 0.03). There was no significant difference in quality of life and medication adherence between groups at any follow-up time point.
CONCLUSIONS: In this first French real-life study, the advice provided by qualified nurses via phone calls improved the management of grade 3 toxicities but failed to demonstrate an improvement of all grades of toxicities. More prospective studies are needed to confirm the impact of telephone calls on the toxicities related to OAD.
TRIAL REGISTRATION: Clinical trial registration is NCT02459483. Protection committee SUD-ESTI registration is 2015-A00527-42 on 13 April 2015. National Agency for the Safety of Medicines and Health Products registration is 150619-B on the 27 may 2015.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer - 29(2021), 8 vom: 06. Aug., Seite 4257-4267 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bouleftour, Wafa [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 23.07.2021 Date Revised 23.07.2021 published: Print-Electronic ClinicalTrials.gov: NCT02459483 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00520-020-05955-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319734714 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319734714 | ||
| 003 | DE-627 | ||
| 005 | 20231225172059.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00520-020-05955-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1065.xml |
| 035 | |a (DE-627)NLM319734714 | ||
| 035 | |a (NLM)33409726 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bouleftour, Wafa |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents |b a randomized, multicenter controlled trial (ETICCO study) |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.07.2021 | ||
| 500 | |a Date Revised 23.07.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ClinicalTrials.gov: NCT02459483 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a PURPOSE: The use of oral cancer drugs (OAD) has increased over the last two decades. The objective of this study was to measure the impact of a nurse-led telephone follow-up in the therapeutic management of patients treated with an OAD regarding toxicity, medication adherence and quality of life | ||
| 520 | |a METHODS: A randomized, multicenter, controlled trial was conducted. All consecutive over 18-year-old patients, treated in medical oncology, radiotherapy, or hematology departments, receiving OAD for any cancer were invited to participate to the study. A total of 183 patients treated for solid or hematological cancers with an OAD were randomly assigned to receive a nurse-led telephone follow-up or standard care for 24 weeks. Data were collected between 2015 and 2018 | ||
| 520 | |a RESULTS: Nurse telephone follow-up did not improve the global score toxicity in the intervention group. However, telephone calls directed by trained nurses induced a significant decrease in number of patients with grade 3 adverse events throughout the follow-up [OR 0.45 (IC à 95%) (0.23, 0.9)](P = 0.03). There was no significant difference in quality of life and medication adherence between groups at any follow-up time point | ||
| 520 | |a CONCLUSIONS: In this first French real-life study, the advice provided by qualified nurses via phone calls improved the management of grade 3 toxicities but failed to demonstrate an improvement of all grades of toxicities. More prospective studies are needed to confirm the impact of telephone calls on the toxicities related to OAD | ||
| 520 | |a TRIAL REGISTRATION: Clinical trial registration is NCT02459483. Protection committee SUD-ESTI registration is 2015-A00527-42 on 13 April 2015. National Agency for the Safety of Medicines and Health Products registration is 150619-B on the 27 may 2015 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Education of patients | |
| 650 | 4 | |a Oral antineoplastic drugs | |
| 650 | 4 | |a Safety monitoring | |
| 650 | 4 | |a Side-effect prevention | |
| 650 | 4 | |a Telephone | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 700 | 1 | |a Muron, Thierry |e verfasserin |4 aut | |
| 700 | 1 | |a Guillot, Aline |e verfasserin |4 aut | |
| 700 | 1 | |a Tinquaut, Fabien |e verfasserin |4 aut | |
| 700 | 1 | |a Rivoirard, Romain |e verfasserin |4 aut | |
| 700 | 1 | |a Jacquin, Jean-Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Saban-Roche, Léa |e verfasserin |4 aut | |
| 700 | 1 | |a Boussoualim, Karima |e verfasserin |4 aut | |
| 700 | 1 | |a Tavernier, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Augeul-Meunier, Karine |e verfasserin |4 aut | |
| 700 | 1 | |a Collard, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Mery, Benoite |e verfasserin |4 aut | |
| 700 | 1 | |a Pupier, Sidonie |e verfasserin |4 aut | |
| 700 | 1 | |a Oriol, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Bourmaud, Aurélie |e verfasserin |4 aut | |
| 700 | 1 | |a Fournel, Pierre |e verfasserin |4 aut | |
| 700 | 1 | |a Vassal, C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer |d 1994 |g 29(2021), 8 vom: 06. Aug., Seite 4257-4267 |w (DE-627)NLM07487618X |x 1433-7339 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2021 |g number:8 |g day:06 |g month:08 |g pages:4257-4267 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00520-020-05955-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2021 |e 8 |b 06 |c 08 |h 4257-4267 | ||